Published in Law and Health Weekly, May 8th, 2004
At the meeting, the company discussed steps it has taken to address the issues raised by OIVD in its letter.
Consistent with these discussions, the company will continue to make its HPV ASR products available to its customers.
Ventana develops, manufactures, and markets instrument/reagent systems that automate slide preparation and staining in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.